Latest News about MRK
Recent news which mentions MRK
   Merck Injects $1 Billion To Expand Vaccine Production In US
   
  
  
  March 11, 2025
  From Benzinga
 From Motley Fool
 
   5 Top Stocks to Buy for March
   
  
  
  March 08, 2025
  From Motley Fool
 From Benzinga
 From Benzinga
 
   These Vanguard ETFs Show Where the Smart Money Is Moving Now
   
  
  
  March 03, 2025
  From Motley Fool
 
   Decoding Merck & Co's Options Activity: What's the Big Picture?
   
  February 27, 2025
  Tickers 
   MRK
  
  
  From Benzinga
 
   NovoCure Q4 EPS Misses, Revenue Matches
   
  
  
  February 27, 2025
  From Motley Fool
 From Motley Fool
 
   Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
   
  
  
  February 24, 2025
  From Motley Fool
 From Benzinga
 
   Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
   
  
  
  February 19, 2025
  From Benzinga
 
   Europe Approves Merck's Cancer Drug For Two Indications
   
  
  
  February 18, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 
   Beyond The Numbers: 13 Analysts Discuss Merck & Co Stock
   
  February 18, 2025
  Tickers 
   MRK
  
  
  From Benzinga
 
   Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
   
  
  
  February 18, 2025
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  February 14, 2025
  From Benzinga
 
   Decoding Merck & Co's Options Activity: What's the Big Picture?
   
  February 13, 2025
  Tickers 
   MRK
  
  
  From Benzinga
 
   Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
   
  
  
  February 13, 2025
  From Benzinga
 
   3 Blue-Chip Dividend Stocks Trading at Multiyear Lows
   
  
  
  February 13, 2025
  From Motley Fool
 
   Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
   
  
  
  February 13, 2025
  From Motley Fool
 
   Gilead Sciences Beats Q4 EPS Forecast
   
  
  
  February 11, 2025
  From Motley Fool
 
   Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock
   
  
  
  February 11, 2025
  From Benzinga
 
   Better High-Yield Dividend Stock: Pfizer vs. Merck
   
  
  
  February 10, 2025
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.